# Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

> **NCT01367249** · PHASE3 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 440 (actual)

## Conditions studied

- Pain
- Inflammation
- Cataract

## Interventions

- **DRUG:** Bromfenac Ophthalmic Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01367249
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-07
- **Final completion:** 2011-12
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367249, "Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01367249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*